BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11042096)

  • 1. A pharmacokinetic model for predicting absorption, elimination, and tissue burden of toxaphene in rats.
    Wen YH; Chan HM
    Toxicol Appl Pharmacol; 2000 Nov; 168(3):235-43. PubMed ID: 11042096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat.
    Mirfazaelian A; Kim KB; Anand SS; Kim HJ; Tornero-Velez R; Bruckner JV; Fisher JW
    Toxicol Sci; 2006 Oct; 93(2):432-42. PubMed ID: 16831841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The elimination, distribution, and metabolism of 14C-toxaphene in the pregnant rat.
    Pollock GA; Hillstrand R
    J Environ Sci Health B; 1982; 17(6):635-48. PubMed ID: 7166626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A toxicokinetic model for predicting the tissue distribution and elimination of organic and inorganic mercury following exposure to methyl mercury in animals and humans. I. Development and validation of the model using experimental data in rats.
    Carrier G; Brunet RC; Caza M; Bouchard M
    Toxicol Appl Pharmacol; 2001 Feb; 171(1):38-49. PubMed ID: 11181110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal-fetal pharmacokinetics of methanol.
    Pollack GM; Brouwer KL
    Res Rep Health Eff Inst; 1996 Jun; (74):1-48; discussion 49-53. PubMed ID: 11381741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous absorption and disposition of [14C]chlordecone in young and adult female rats.
    Heatherington AC; Fisher HL; Sumler MR; Waller CL; Shah PV; Hall LL
    Environ Res; 1998 Nov; 79(2):138-55. PubMed ID: 9841813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicokinetics and tissue distribution of deltamethrin in adult Sprague-Dawley rats.
    Kim KB; Anand SS; Kim HJ; White CA; Bruckner JV
    Toxicol Sci; 2008 Feb; 101(2):197-205. PubMed ID: 18056584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat.
    Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C
    Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
    Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
    Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a reference dose for the persistent congeners of weathered toxaphene based on in vivo and in vitro effects related to tumor promotion.
    Simon T; Manning R
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):268-81. PubMed ID: 16472898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats.
    Myers SR; Spinnato JA
    Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toxicokinetic model for predicting the tissue distribution and elimination of organic and inorganic mercury following exposure to methyl mercury in animals and humans. II. Application and validation of the model in humans.
    Carrier G; Bouchard M; Brunet RC; Caza M
    Toxicol Appl Pharmacol; 2001 Feb; 171(1):50-60. PubMed ID: 11181111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological model for the pharmacokinetics of methyl mercury in the growing rat.
    Farris FF; Dedrick RL; Allen PV; Smith JC
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):74-90. PubMed ID: 8470126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation dynamics of chlordanes and their enantiomers in cockerels (Gallus gallus) after oral exposure.
    Lu Z; Xue M; Shen G; Li K; Li X; Wang X; Tao S
    Environ Sci Technol; 2011 Sep; 45(18):7928-35. PubMed ID: 21823571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling.
    Belfiore CJ; Yang RS; Chubb LS; Lohitnavy M; Lohitnavy OS; Andersen ME
    Toxicology; 2007 May; 234(1-2):59-72. PubMed ID: 17382449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue residues, metabolism, and excretion of radiolabeled sodium chlorate (Na[36Cl]O3) in rats.
    Hakk H; Smith DJ; Shappell NW
    J Agric Food Chem; 2007 Mar; 55(5):2034-42. PubMed ID: 17279768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile and placental transfer of a single intravenous injection of [(14)C]chlorpyrifos in pregnant rats.
    Abdel-Rahman AA; Blumenthal GM; Abou-Donia SA; Ali FA; Abdel-Monem AE; Abou-Donia MB
    Arch Toxicol; 2002 Aug; 76(8):452-9. PubMed ID: 12185413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excretion and storage of [14C]toxaphene and two isolated [14C]toxaphene fractions.
    Pollock GA; Kilgore W
    J Toxicol Environ Health; 1980 Jan; 6(1):127-40. PubMed ID: 7381966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.